theheart.org: Cardiology news, educational programming, and opinions

Lipid/Metabolic

Lipid Insights From AHA 2009

Nov 20, 2009 15:32 EST

Dr. Michael Davidson, a nationally recognized cardiologist and clinical lipidologist, will lead a targeted discussion focusing on the interpretation and application of results presented at this year's AHA meeting. Joining him will be a distinguished faculty panel, including: Dr. Christie Ballantyne, Director of the Center for Cardiovascular Disease Prevention at Baylor College of Medicine; Dr. Vera Bittner, Section Head of Preventive Cardiology at the University of Alabama at Birmingham and President of the National Lipid Association; and Dr. Roger Blumenthal, Director of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease.

Arrhythmia/EP

Identifying Atrial Fibrillation - Preventing Stroke

Nov 13, 2009 09:32 EST

There is an increasing epidemic; the threat is real. With prevalence up and recent therapeutic advances few, atrial fibrillation and the accompanying risk for stroke need to be uppermost in the minds of physicians caring for patients with cardiovascular risk factors. Join Dr. Jerry Naccarelli as he leads a panel of experts consisting of Drs. Osseroff, Capucci and Lau, in a discussion of this global problem.

Interventional/Surgery

PCI in Left Main Disease: Are We There Yet?

1 COMMENT - Nov 11, 2009 11:41 EST

SYNTAX and MAIN-COMPARE suggest a role for PCI in subsets of patients with left main disease; however, in current ACC/AHA guidelines this remains a class III indication. Dr. Turco chairs a roundtable with interventionalists Drs Kandzari and Park and surgeon Dr Sabik.

Acute Coronary Syndromes

Focus On: Antiplatelet Therapy at ESC

Oct 30, 2009 10:23 EDT

PLATO, CURRENT-OASIS 7, and further analyses of PPIs and thienopyridines; read Dr Prasad's review of recent data presented at ESC; and watch presentations by Drs Mehran, O'Donoghue, Storey, and Wiviott.

Acute Coronary Syndromes

Tips and Approaches to Reducing Bleeding in PCI

1 COMMENT - Oct 29, 2009 10:37 EDT

Join Drs. Bhatt, Rao, and Stone as they discuss important clinical trial data which will improve management strategies for patients undergoing PCI.

Acute Coronary Syndromes

The Role of Antiplatelet Therapy in the Management of Patients with NSTE ACS

Oct 28, 2009 10:46 EDT

In the US, each year over 1.4 million people will be hospitalized for unstable angina (UA) and non-ST-segment-elevation myocardial infarction (NSTEMI). Multiple antiplatelet agents have been developed to interfere with or inhibit the specific pathways of platelet activation and aggregation that lead to the development of UA and NSTEMI. Join Drs Newby, Popma, and Wiviot as they discuss.

Interventional/Surgery

TAVI vs AVR Patient Selection

Oct 27, 2009 14:49 EDT

The PARTNER and PAVIS trials of transcatheter aortic valve implementation will include inoperable or very high-surgical-risk patients. In Europe, where the devices have been approved for a few years, the technology is being expanded to lesser-risk patients. Interventionalist Dr Jeffrey Popma discusses the selection of patients with surgeon Dr Mathew Williams.

Arrhythmia/EP

New Therapeutic Strategies in the Management of Atrial Fibrillation

Oct 27, 2009 11:31 EDT

Atrial fibrillation is associated with a high risk for stroke, myocardial infarction, heart failure, and death. How does blockade of the renin-angiotensin system affect patient outcomes? Join our international panel of experts, Drs Camm, Connolly, Crijns, and Granger, as they discuss the ESC 09 hotline results of the ACTIVE-I trial.

Interventional/Surgery

Emerging Stent Technologies: Adding Innovation and New Science to Clinical Practice

Oct 20, 2009 13:38 EDT

Dr. Dean Kereiakes leads an international panel of experts, Drs. Meredith, Banning, and Hermiller, as they discuss fascinating developments in stent and polymer technology and design their "dream stent."

Arrhythmia/EP

Preventing Stroke in Patients With Atrial Fibrillation: Late-Breaking Clinical Trial Data From ESC 2009

Oct 19, 2009 14:03 EDT

Read Dr. Jonathan Piccini's review of prevention of stroke in AF and how the newly released results of clinical trials of novel antithrombotic agents will reduce the risk for stroke. Then listen to our international panel of experts, Drs. Camm, Granger, Prystowsky, and Yusuf, as they give their take on new data released at ESC 2009.

Interventional/Surgery

Drug-Eluting Stents: Head-to-Head Clinical Trial Results

Oct 16, 2009 11:06 EDT

How do drug-eluting stents compare? Our panel of experts, Drs. Stone, Kereiakes, Serruys, and Windecker discuss the late-breaking trials at TCT 2009 of DES vs DES.

Acute Coronary Syndromes

Antiplatelet Therapy in ACS: The Latest Dialogues

Oct 15, 2009 16:09 EDT

PLATO, the ESC late-breaking trial, compared a novel direct-acting reversible P2Y12 antagonist with clopidogrel in ACS patients undergoing PCI. Dr. Keith Fox leads a discussion with the PI, Dr. Lars Wallentin, and Dr. Deepak Bhatt.

Clinical cardiology

New Data and the Clinical Implications on the Use of High Loading and Maintenance Doses of Clopidogrel

1 COMMENT - Oct 15, 2009 09:58 EDT

What effect does doubling the dose of clopidogrel have on outcomes in patients undergoing PCI? Dr. Salim Yusuf discusses the results of the CURRENT-OASIS 7 trial and other new data on antithrombotic agents.

Arrhythmia/EP

Does Early Intervention With CRT-D Improve Outcomes for Patients With Heart Failure?

2 COMMENTS - Oct 9, 2009 13:43 EDT

Dr. Ileana Piña discusses the design and outcomes of the MADIT-CRT trial with Drs. Moss and Estes, and how these new data may benefit patients with heart failure.

Heart failure

Diagnosing and Treating Chest Discomfort of Cardiovascular Origin: The Role of Risk Stratification

1 COMMENT - Oct 8, 2009 11:04 EDT

An older patient appearing obviously fatigued and "worn out" presents in the office complaining of heaviness in the chest, and shortness of breath especially with any type of exercise. Not your typical angina patient, or is it? How do you go about working up this patient to make the right diagnosis? Drs. Pepine and Wenger discuss the approach to patients with ischemia and treatment considerations.

Interventional/Surgery

Revascularization in Patients With Diabetes

Oct 7, 2009 14:12 EDT

Since BARI, CABG has been the gold standard for patients with diabetes and multivessel disease. However, SYNTAX suggests an increasing role for PCI and BARI 2D highlights the importance of optimal medical therapy. Dr. Boden leads a multidisciplinary discussion with Drs. Holmes and Taggart.

Arrhythmia/EP

Making the Case for Guideline-Driven Care in the Outpatient HF Setting

Oct 7, 2009 10:41 EDT

Evidence-based therapies, both pharmacologic and devices are well documented in published guidelines, but are they followed and implemented in practice? Is there a treatment gap? Is it all about education or the lack thereof? Drs. Yancy, Abraham, and Pfeffer confer on evidence from recent registries and trials.

Arrhythmia/EP

In Depth Review of Late-Breaking Clinical Trials in AF Stoke Prevention

Oct 5, 2009 11:55 EDT

Join our international panel of experts, Drs. Lip, Halperin, Weitz, Ezekowitz, Wallentin, and Connolly as they present late-breaking results of the RE-LY trial.

Heart failure

Novel Approaches to Enhancing Myocardial Contractility for the Treatment of Acute and Chronic HF

1 COMMENT - Oct 1, 2009 15:37 EDT

Despite improvements in the treatment of HF, morbidity and mortality remain a pressing public health issue. Disappointing and controversial results with positive inotropic agents have driven the search for new mechanisms and approaches to improve cardiac performance. Drs. Greenberg, Felker, McMurray, and Pfeffer explore these new possibilities.

Interventional/Surgery

Dual Antiplatelet Therapy: Dueling Options in Real-World Practice

2 COMMENTS - Sep 30, 2009 13:31 EDT

With the recent approval of a third-generation thienopyridine, choice of agent can be added to the list of considerations in the management of ACS patients, as well as the appropriate timing and dosing of thienopyridine. Using some case vignettes, Dr. King leads a discussion with Drs. Bhatt and Steg on their clinical decision-making.

Arrhythmia/EP

Redefining the Therapeutic Goals of Atrial Fibrillation

3 COMMENTS - Sep 22, 2009 14:20 EDT

AF is sometimes considered a benign or nuisance condition. However, it is vital that it is recognized as a harbinger of underlying cardiovascular disease, and that it is diagnosed early and treated appropriately. Join Drs. Kirchhof, Dorian, Marrouche, and Steg as they discuss strategies to reduce the complications of AF.

Acute Coronary Syndromes

Best Practices for the Treatment of STEMI: How Can We Decrease Mortality?

Sep 21, 2009 09:56 EDT

Patients presenting with STEMI represent a high-risk population. Thrombotic and bleeding complications contribute to mortality in these patients. Join Drs. Steg, Hamm, Hill, and Mehran as they discuss best practices for the treatment of STEMI patients with a focus on preventing bleeding complications.

Acute Coronary Syndromes

In Brief: Optimal Use of Dual Antiplatelet Therapy...

Sep 15, 2009 15:44 EDT

Antiplatelet therapy is key for the prevention of secondary events in ACS patients. Dr. Ardissino introduces a series of brief presentations by Drs. Angiolillo, Fernánadez-Avilés, Montalescot, and Neumann on the optimal use of antiplatelets in ACS patients undergoing PCI, including those with diabetes and those at high bleeding risk.

Imaging

Risk Stratification in Heart Failure: Imaging Update From ESC 2009

Aug 28, 2009 11:34 EDT

Drs. Yancy, Bax, and O′Connor ponder the implications of new data related to imaging risk stratification in special patient populations.

Acute Coronary Syndromes

Antiplatelet Therapy in PCI: Addressing Unmet Needs

Aug 28, 2009 11:29 EDT

How will the prasugrel approval and the upcoming PLATO and CURRENT-OASIS 7 trials affect antiplatelet options for ACS patients undergoing PCI? Read a summary of the latest data, with expert input from Drs. Ardissino and Montalescot.

	Yes
	No